medigraphic.com
ISSN 0188-9796 (Print)

2011, Number 2

<< Back Next >>

Rev Endocrinol Nutr 2011; 19 (2)

Localization of clinically-significant macular edema in diabetic patients without visual loss

Razo-Blanco-Hernández DM, Pérez-Beltrán AV, Lima-Gómez V

Language: Spanish
References: 20
Page: 62-68
PDF size: 82.66 Kb.


ABSTRACT

Background: Clinically significant macular edema (CSME) causes visual loss in diabetic patients. Although it can be detected before vision is affected, it is unknown whether any zone of the macula is more frequently affected in eyes without visual loss. Objective: To identify whether CSME is statistically more frequent in any zone of the macula, in eyes without visual loss. Methods: Non-interventional, retrospective, cross-sectional and comparative study. Type 2 diabetic patients with angiographic focal CSME, with any retinopathy level and clear ocular media, were assigned to one of two groups: with or without visual loss (best corrected visual acuity ≤ 20/40). The proportion of cases with thickening in each field of the fast macular map (optical coherence tomography) was compared between eyes with and without visual loss using χ2. In eyes without visual loss, the frequency of thickening in each field was compared with that of the remaining fields (χ2). Results: 90 eyes were evaluated; mean age 60.3 years. Thickening distribution did not differ between eyes with and without visual loss. In eyes without visual loss, thickening was more frequent in fields 5 (inner nasal, 98%, 95% C.I. 94-100) and 4 (inner inferior, 96%, 95% C.I. 90-100). The frequency of thickening in both fields was higher than that of other fields. Conclusion: In diabetic patients without visual loss, inferior and nasal areas adjacent to the center of the macula should be evaluated, since CSME affects them more frequently than other areas.


REFERENCES

  1. Cheung N, Mitchel P, Wong TY. Diabetic retinopathy. Lancet 2010; 376: 124-136.

  2. Bhagat N, Grigorian RA, Tutela A, Zarbin MA. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol 2009; 54: 1-32.

  3. American Academy of Ophthalmology Retina Panel. Diabetic retinopathy. Preferred Practice Pattern Guidelines. San Francisco CA, American Academy of Ophthalmology; 2008.

  4. Varma R, Choudhury F, Klein R, Chung J, Torres M, Azen SP. Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study. Am J Ophthalmol 2010; 149: 752-761.

  5. Asociación Mexicana de Retina, Sociedad Mexicana de Oftalmología, Asociación Panamericana de Oftalmología. Resultados del Día Panamericano de detección de retinopatía diabética (3 de julio de 1999, Día “D”). Rev Mex Oftalmol 2005; 79: 88-92.

  6. Lima-Gómez V, Olivares-Morales OE, Razo-Blanco-Hernández DM, Hernández-Rojas ML. Deficiencia visual al momento del diagnóstico del edema macular clínicamente significativo en diabéticos mexicanos. Salud Publica Mex 2008; 50: 354-355.

  7. Gill JM, Cole DM, Lebowits HM, Diamond JJ. Accuracy of screening for diabetic retinopathy by family physicians. Ann Fam Med 2004; 2: 218-220.

  8. Razo-Blanco HDM, Cuan M, Lima Gomez V. Eficacia de la exploración del haz papilomacular para la detección del edema macular diabético. Rev Hosp Jua Mex 2009; 76: 186-189.

  9. Voo I, Mavrofrides EC, Puliafito CA. Clinical applications of optical coherence tomography for the diagnosis and management of macular diseases. Ophthalmol Clin North Am 2004; 17: 21-31.

  10. Polito A, Del Borrello M, Isola M, Zemella N, Bandello F. Repeatability and reproducibility of fast macular thickness mapping with stratus optical coherence tomography. Arch Ophthalmol 2005; 123: 1330-1337.

  11. Lima-Gómez V. Distribución topográfica del edema macular diabético por tomografía de coherencia óptica. Rev Mex Oftalmol 2007; 81: 321-325.

  12. Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, Dills D et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003; 110: 1677-1682.

  13. Sadda SR, Wu Z, Walsh AC, Richine L, Dougall J, Cortez R et al. Errors in retinal thickness measurements obtained by optical coherence tomography. Ophthalmology 2006; 113: 285-293.

  14. Lima-Gómez V, Osornio CNA. Comparación del grosor retiniano en diabéticos sin retinopatía, con y sin fondo coroideo. Rev Mex Oftalmol 2006; 80: 301-305.

  15. Lima-Gómez V, Razo-Blanco-Hernández DM, Muñoz-Ibarra P, Hernández-Rojas ML. Distribución de la gravedad del edema macular diabético al momento del diagnóstico. Cir Ciruj 2011; 79: en prensa.

  16. de Fine Olivaruis N, Siersma V, Almind GJ, Nielsen NV. Prevalence and progression of visual impairment in patients newly diagnosed with clinical type 2 diabetes: a 6 year follow up study. BMC Public Health 2011; 11: 80.

  17. Towler HMA, Patterson JA, Lightman S. Diabetes and the eye. London; BMJ Publishing Group, 1996.

  18. Bhattacharjee S. Diabetic retinopathy: need for awareness amongst physicians. J Indian Med Assoc 2002; 100: 153-154.

  19. De los Terreros AS, Auillo E, Faure E, Domene R, Ibañez J, Garijo C. Reliability of stereoscopic nonmydriatic retinography for assessment of diabetic macular edema when performed by endocrinologists. Diabetes Technol Ther 2010; 12: 179-183.

  20. Germain N, Galusca B, Deb-Joardar N, Millot L, Manoli P, Thuret G et al. No loss of chance of diabetic retinopathy screening by endocrinologists with a digital fundus camera. Diabetes Care 2011; 34: 580-585.




2020     |     www.medigraphic.com